Ersefuryl capsules 200mg, 28pcs

Composition

1 capsule contains nifuroxazide 200 mg;

excipients:

sucrose 72 mg,

magnesium stearate 1.8 mg,

corn starch 88 mg;

capsule shell composition:

gelatin,

titanium dioxide,

iron oxide yellow,

water.

Pharmacological action

Ersefuril is an intestinal antiseptic, an antidiarrheal drug. Like other nitrofurans, it blocks some redox enzyme reactions in microbial cells. When used in therapeutic doses, it has a bacteriostatic effect, in high doses – bactericidal. It is active against gram-positive (Staphylococcus, Streptococcus, Clostridium) and Gram-negative (Escherichia coli, Salmonella, Shigella, Klebsiela, Enterobacter, Vibrio cholerae, etc. ) microorganisms.

It does not affect saprophytic flora (it does not cause dysbiosis). Bacterial strains do not develop resistance to the drug.

Indications

Acute bacterial diarrhea.

Use during pregnancy and lactation

The use of the drug during pregnancy is possible only if the intended benefit to the mother outweighs the potential risk to the fetus.

It can be prescribed to nursing women.

Contraindications

Hypersensitivity (including to other nitrofuran derivatives); children under 6 years of age.

Side effects

Allergic reactions such as skin rashes, urticaria, angioedema, or anaphylactic shock are extremely rare.

Interaction

Taking ethanol may cause hypersensitivity symptoms.

It is not recommended to take the drug in combination with drugs that lead to reactions such as withdrawal syndrome or antidepressants.

How to take, course of use and dosage

Ersefuril is taken orally, adults – 1 capsule (200 mg) 4 times a day (800 mg).

Children over 6 years of age – 200 mg 3 times a day (600 mg).

The duration of the course of treatment is no more than 7 days.

Special instructions

Rehydration should be performed if necessary.

The volume of fluid administered and the method of its use (inside, in/in) should correspond to the severity of diarrhea, age and clinical condition of the patient.

In the case of infectious diarrhea with clinical symptoms that indicate an invasive phenomenon, systematic antibacterial therapy is necessary.

Due to the presence of sucrose in the preparation, it should not be prescribed for fructose intolerance, glucose-galactose malabsorption syndrome or sucrose-isomaltase deficiency.

Form of production

Capsules.

Storage conditions

In a dry place, at a temperature not exceeding 30 °C

Shelf life

5 years

Active ingredient

Nifuroxazide

Dosage form

Capsules

Description

For adults, Nursing mothers as prescribed by a doctor, Children over 6 years of age

Indications

Diarrhea, Poisoning, Intestinal Infections, Salmonellosis